Healthcare -
Biotechnology - NASDAQ - US
$ 9.135
-2.82 %
$ 774 M
Market Cap
-1.15
P/E
IMNM - COST OF REVENUE
Cost of Revenue IMNM - Immunome, Inc.
22.9 M
LAST VALUE
451.04%
2 YEAR CAGR
113.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR